Back
36
Also listed as
CJEWY
OTC
Day Range
$1.90
$1.90
52-Week Range
$0.92
$2.17
Volume
300
50D / 200D Avg
$1.77
/
$1.72
Prev Close
$1.90
Price History
Financial Trends
Peer Comparison
vs Consumer Cyclical sector median (609 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 3.2 | 11.2 |
| P/B | 0.7 | 1.4 |
| ROE % | 22.7 | 10.7 |
| Net Margin % | 6.6 | 5.1 |
| Rev Growth 5Y % | 6.3 | 8.3 |
| D/E | 0.8 | 0.8 |
Key Takeaways
Revenue grew 6.32% annually over 5 years — modest growth
ROE of 22.69% indicates high profitability
Generating 9.68B in free cash flow
P/E of 3.17 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 23.85%
Cash machine — converts 163.58% of earnings into free cash flow
Growth
Revenue Growth (5Y)
6.32%
Revenue (1Y)-17.53%
Earnings (1Y)-8.98%
FCF Growth (3Y)9.41%
Quality
Return on Equity
22.69%
ROIC22.42%
Net Margin6.60%
Op. Margin15.74%
Safety
Debt / Equity
0.79
Current Ratio1.40
Interest Coverage23.81
Valuation
P/E Ratio
3.17
P/B Ratio0.71
EV/EBITDA2.26
Dividend Yield0.07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -17.53% | Revenue Growth (3Y) | -2.69% |
| Earnings Growth (1Y) | -8.98% | Earnings Growth (3Y) | 4.82% |
| Revenue Growth (5Y) | 6.32% | Earnings Growth (5Y) | -0.46% |
| Profitability | |||
| Revenue (TTM) | 89.66B | Net Income (TTM) | 5.92B |
| ROE | 22.69% | ROA | 7.73% |
| Gross Margin | 29.51% | Operating Margin | 15.74% |
| Net Margin | 6.60% | Free Cash Flow (TTM) | 9.68B |
| ROIC | 22.42% | FCF Growth (3Y) | 9.41% |
| Safety | |||
| Debt / Equity | 0.79 | Current Ratio | 1.40 |
| Interest Coverage | 23.81 | Dividend Yield | 0.07% |
| Valuation | |||
| P/E Ratio | 3.17 | P/B Ratio | 0.71 |
| P/S Ratio | 0.21 | PEG Ratio | -1.31 |
| EV/EBITDA | 2.26 | Dividend Yield | 0.07% |
| Market Cap | 18.74B | Enterprise Value | 31.95B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 89.66B | 108.71B | 94.68B | 98.94B | 70.16B |
| Net Income | 5.92B | 6.50B | 5.38B | 6.71B | 6.03B |
| EPS (Diluted) | 0.59 | 0.65 | 0.54 | 0.67 | 0.60 |
| Gross Profit | 26.45B | 22.29B | 21.17B | 22.34B | 20.07B |
| Operating Income | 14.12B | 9.09B | 8.06B | 9.34B | 9.07B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 76.52B | 88.82B | 87.34B | 87.74B | 64.31B |
| Total Liabilities | 49.13B | 62.07B | 53.98B | 53.18B | 32.74B |
| Shareholders' Equity | 26.43B | 25.72B | 32.40B | 33.62B | 30.77B |
| Total Debt | 20.79B | 29.89B | 22.11B | 25.98B | 13.64B |
| Cash & Equivalents | 7.58B | 7.70B | 11.70B | 14.94B | 6.03B |
| Current Assets | 67.27B | 79.18B | 77.27B | 78.13B | 55.24B |
| Current Liabilities | 48.13B | 57.52B | 51.02B | 49.63B | 29.14B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#262 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026